Esterase activities in the blood, liver and intestine of several preclinical species and humans.
By L. Berry, Lance A. Wollenberg, Zhiyang Zhao. 2009
107 citations recorded by the source corpus.
Subfields: Epidemiology, Pharmacology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Benjamin N. Atkinson
- N. Willis
- Yuguang Zhao
- C. Patel
- S. Frew
- K. Costelloe
- Fredrik Svensson
- L. Magno
Citations in the corpus
- Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity (2023, background): “Replacement of the ester would prevent acylation of Ser232 and likely improve stability as esters can be vulnerable to plasma and liver esterases [23].”